Consumer Prices Rise 38 Annually in April Exceeding Expectations
AIGenerated Fake Evidence Scandal Korean Actor Kim Soohyuns Career Threatened Police Seek Arrest Warrant for YouTuber
Manchester City Faces Leadership Transition Enzo Maresca Emerges as Potential Guardiola Successor
Surging Gas Prices Disproportionately Impact LowerIncome Households New York Fed Study Suggests
Tech Rally Propels SP 500 to New Record on May 26 2026
Telematics Reshapes Auto Insurance Risk Assessment
Coffee Holding Co Inc JVA Q4 2019 Earnings EPS Misses Estimates by Wide Margin Amid Ongoing Industry Challenges
Manchester United Q1 2026 Earnings Strong EPS Surprise Amid Revenue Disparities
Redwood Trust Inc 9125 Senior Notes Due 2029 RWTN Q1 2026 Earnings Earnings Miss but Positive Market Response
BKD Q1 2026 Earnings EPS Misses Estimates by 35 as Senior Housing Operator Faces Headwinds
XRTX Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue RD Costs Shares Climb
VALU Q1 2026 Earnings EPS of 069 Amid Market Headwinds
LDP Edges Higher as Preferred Income Fund Maintains Support Level
Western Midstream Partners WES Rises 161 as Energy Infrastructure Demand Supports Uptrend
Bluerock Acquisition Corp BLRK Holds Steady Near NAV Amid Merger Uncertainty
Global Interactive Technologies GITS Faces Sharp Pullback Tests Key Support at 152
Sinclair Inc SBGI Gains 12 Approaching Key Resistance at 1502
Warren Buffetts Timeless Investing Wisdom 3 Simple Rules for LongTerm Success
IDEX Corporation Q1 2026 Earnings Strong EPS Beat Drives Stock Uptick
SELLAS Life Sciences Group SLS Gains Ground Biotech Stock Tests Key Resistance After 476 Rally
RVLV Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher
Zepp Health Q3 2025 Earnings Loss Per Share of 004 Amidst Market Challenges
SLM Q1 2026 Earnings EPS Surges Past Estimates by 356 Stock Slips
BG Q1 2026 Earnings Strong EPS Surprise as Agribusiness Margins Improve
BNL Q1 2026 Earnings Strong EPS Surprise on Adjusted Earnings Revenue Not Disclosed
ZNB Q4 2011 Earnings Massive EPS Beat of 523 Powered by Exceptional Quarter
NRX Pharmaceuticals Q1 2026 Earnings Wider Loss Despite No Revenue Stock Advances